Swiss National Bank Aurinia Pharmaceuticals Inc. Transaction History

Swiss National Bank

  • $146 Billion
  • Q4 2024

A detailed history of Swiss National Bank transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Swiss National Bank holds 239,000 shares of AUPH stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
239,000
Previous 265,200 9.88%
Holding current value
$1.95 Million
Previous $1.94 Million 10.45%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$6.75 - $10.44 $176,850 - $273,528
-26,200 Reduced 9.88%
239,000 $2.15 Million
Q3 2024

Nov 07, 2024
SELL
$5.32 - $7.33 $17,556 - $24,189
-3,300 Reduced 1.23%
265,200 $1.94 Million
Q4 2023

Feb 06, 2024
SELL
$7.13 - $9.49 $215,326 - $286,598
-30,200 Reduced 10.11%
268,500 $2.41 Million
Q3 2023

Nov 08, 2023
BUY
$7.77 - $12.27 $150,738 - $238,038
19,400 Added 6.95%
298,700 $2.32 Million
Q2 2023

Aug 09, 2023
BUY
$8.96 - $11.69 $166,656 - $217,434
18,600 Added 7.13%
279,300 $2.7 Million
Q1 2023

May 10, 2023
SELL
$5.94 - $11.27 $181,170 - $343,735
-30,500 Reduced 10.47%
260,700 $2.86 Million
Q4 2022

Feb 08, 2023
BUY
$4.11 - $8.14 $22,605 - $44,770
5,500 Added 1.93%
291,200 $1.26 Million
Q3 2022

Nov 09, 2022
BUY
$6.66 - $12.39 $167,166 - $310,989
25,100 Added 9.63%
285,700 $2.15 Million
Q1 2022

May 09, 2022
BUY
$10.05 - $22.48 $205,020 - $458,592
20,400 Added 8.49%
260,600 $3.23 Million
Q4 2021

Feb 08, 2022
BUY
$17.78 - $33.08 $243,586 - $453,196
13,700 Added 6.05%
240,200 $5.49 Million
Q3 2021

Nov 08, 2021
BUY
$10.93 - $23.55 $10,930 - $23,550
1,000 Added 0.44%
226,500 $5.01 Million
Q2 2021

Aug 06, 2021
SELL
$10.0 - $14.52 $204,000 - $296,208
-20,400 Reduced 8.3%
225,500 $2.93 Million
Q1 2021

May 07, 2021
BUY
$12.3 - $18.73 $23,370 - $35,587
1,900 Added 0.78%
245,900 $3.2 Million
Q3 2020

Nov 09, 2020
BUY
$13.19 - $16.66 $836,246 - $1.06 Million
63,400 Added 35.11%
244,000 $3.58 Million
Q2 2020

Aug 05, 2020
BUY
$14.12 - $18.33 $327,584 - $425,255
23,200 Added 14.74%
180,600 $2.91 Million
Q1 2020

May 08, 2020
BUY
$11.34 - $21.46 $55,566 - $105,154
4,900 Added 3.21%
157,400 $2.24 Million
Q4 2019

Feb 06, 2020
BUY
$3.88 - $21.42 $118,340 - $653,310
30,500 Added 25.0%
152,500 $3.08 Million
Q3 2019

Nov 12, 2019
BUY
$5.34 - $6.59 $54,468 - $67,218
10,200 Added 9.12%
122,000 $651,000
Q2 2019

Aug 02, 2019
BUY
$6.05 - $6.75 $82,885 - $92,475
13,700 Added 13.97%
111,800 $738,000
Q4 2018

Feb 13, 2019
BUY
$5.08 - $6.83 $28,956 - $38,931
5,700 Added 6.17%
98,100 $667,000
Q4 2017

Feb 07, 2018
BUY
$4.53 - $7.09 $418,572 - $655,116
92,400
92,400 $421,000

Others Institutions Holding AUPH

# of Institutions
227
Shares Held
58.9M
Call Options Held
949K
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.16B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email